Literature DB >> 4609602

Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

J L Cohen, L E Irwin, G J Marshall, H Darvey, J R Bateman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4609602

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  25 in total

Review 1.  The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors:  H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

Review 2.  Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.

Authors:  Masatoshi Tomita; Yoichi Aoki; Kenichi Tanaka
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracil.

Authors:  J F Belliveau; M R Posner; G W Crabtree; A B Weitberg; M C Wiemann; F J Cummings; G P O'Leary; E Ingersoll; P Calabresi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  A sensitive assay of 5-fluorouracil in plasma by gas chromatography-mass spectrometry.

Authors:  B L Hillcoat; M Kawai; P B McCulloch; J Rosenfeld; C K Williams
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 5.  The practical benefits of pharmacokinetics in the use of antineoplastic agents.

Authors:  C Erlichman; R C Donehower; B A Chabner
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 6.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

7.  Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Authors:  D S Alberts; S E Salmon; H S Chen; T E Moon; L Young; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Intestinal 5-fluorouracil absorption: use of Ussing chambers to assess transport and metabolism.

Authors:  P Smith; C Mirabelli; J Fondacaro; F Ryan; J Dent
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

9.  Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.

Authors:  Sherry Morgan-Meadows; James P Thomas; Daniel Mulkerin; Jordan D Berlin; Howard Bailey; Kim Binger; Jennifer Volkman; Dona Alberti; Chris Feierabend; Rebecca Marrocha; Rhoda Z Arzoomanian; George Wilding
Journal:  Invest New Drugs       Date:  2002-11       Impact factor: 3.850

10.  The influence of cimetidine on the pharmacokinetics of 5-fluorouracil.

Authors:  V J Harvey; M L Slevin; M R Dilloway; P I Clark; A Johnston; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.